Carrier design: cytotoxicity and immunogenicity of synthetic branched polypeptides with poly(L-lysine) backbone
- 31 March 1992
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 19 (1-3) , 231-243
- https://doi.org/10.1016/0168-3659(92)90079-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Recent advances in solid-phase peptide synthesis and preparation of antibodies to synthetic peptidesBiologicals, 1990
- Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatinCancer Immunology, Immunotherapy, 1989
- Biodegradability of Synthetic Branched Polypeptide with Poly(L-lysine) backboneBiological Chemistry Hoppe-Seyler, 1989
- Application of marfey's reagent in racemization studies of amino acids and peptidesJournal of Chromatography A, 1988
- Monoclonal Antibody Modification with Chelate-Linked High-Molecular-Weight Polymers: Major Increases in Polyvalent Cation Binding without Loss of Antigen BindingHybridoma, 1987
- Conformation of branched polypeptides based on poly(L-lysine): The effect of terminal amino acids in the branchesCollection of Czechoslovak Chemical Communications, 1985
- Synthesis of new branched polypeptides with poly(lysine)back boneCollection of Czechoslovak Chemical Communications, 1985
- GPC, CD and sedimentation analysis of poly-Lys and branched chain poly-Lys-poly-DL-Ala polypeptidesColloid and Polymer Science, 1984
- Investigation of drug-protein interactions and the drug-carrier concept by the use of branched polypeptides as model systems. Synthesis and characterization of the model peptidesCollection of Czechoslovak Chemical Communications, 1980
- The use of macromolecules as carriers of antitumor drugsPublished by Elsevier ,1977